Puma Biotechnology Inc (PBYI)
4.835
-0.28
(-5.57%)
USD |
NASDAQ |
Apr 24, 16:00
4.835
0.00 (0.00%)
After-Hours: 19:51
Puma Biotechnology Price: 4.835 for April 24, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 23, 2024 | 5.17 | 5.34 | 5.10 | 5.12 | 277093.0 |
| Apr 22, 2024 | 5.01 | 5.27 | 5.00 | 5.17 | 265410.0 |
| Apr 19, 2024 | 4.92 | 5.08 | 4.90 | 5.01 | 290457.0 |
| Apr 18, 2024 | 5.18 | 5.29 | 4.925 | 4.99 | 289054.0 |
| Apr 17, 2024 | 5.10 | 5.30 | 5.05 | 5.17 | 248185.0 |
| Apr 16, 2024 | 5.32 | 5.42 | 5.06 | 5.10 | 285862.0 |
| Apr 15, 2024 | 5.30 | 5.43 | 5.25 | 5.35 | 266547.0 |
| Apr 12, 2024 | 5.37 | 5.521 | 5.212 | 5.27 | 221709.0 |
| Apr 11, 2024 | 5.51 | 5.65 | 5.46 | 5.49 | 145931.0 |
| Apr 10, 2024 | 5.77 | 5.80 | 5.40 | 5.525 | 378662.0 |
| Apr 09, 2024 | 5.61 | 6.055 | 5.59 | 5.83 | 552103.0 |
| Apr 08, 2024 | 5.64 | 5.71 | 5.44 | 5.63 | 315266.0 |
| Apr 05, 2024 | 5.49 | 5.84 | 5.42 | 5.66 | 405403.0 |
| Apr 04, 2024 | 5.40 | 5.57 | 5.36 | 5.51 | 530286.0 |
| Apr 03, 2024 | 5.24 | 5.35 | 5.10 | 5.35 | 337167.0 |
| Apr 02, 2024 | 5.16 | 5.33 | 5.05 | 5.28 | 375493.0 |
| Apr 01, 2024 | 5.42 | 5.42 | 5.12 | 5.28 | 400922.0 |
| Mar 28, 2024 | 5.56 | 5.60 | 5.242 | 5.30 | 275380.0 |
| Mar 27, 2024 | 5.63 | 5.74 | 5.38 | 5.58 | 357785.0 |
| Mar 26, 2024 | 5.67 | 5.676 | 5.37 | 5.60 | 528485.0 |
| Mar 25, 2024 | 5.31 | 5.72 | 5.25 | 5.59 | 738420.0 |
| Mar 22, 2024 | 5.28 | 5.55 | 5.164 | 5.33 | 924299.0 |
| Mar 21, 2024 | 4.67 | 5.39 | 4.62 | 5.35 | 1.168M |
| Mar 20, 2024 | 4.40 | 4.74 | 4.24 | 4.695 | 599716.0 |
| Mar 19, 2024 | 4.47 | 4.58 | 4.14 | 4.30 | 1.097M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.64
Minimum
May 11 2022
34.06
Maximum
Apr 24 2019
6.939
Average
6.28
Median
Mar 17 2020
Price Benchmarks
| ADMA Biologics Inc | 6.46 |
| Regeneron Pharmaceuticals Inc | 906.80 |
| Sarepta Therapeutics Inc | 124.25 |
| CytomX Therapeutics Inc | 1.64 |
| Mirum Pharmaceuticals Inc | 24.02 |
Price Related Metrics
| PE Ratio | 10.74 |
| PS Ratio | 0.9756 |
| Price to Book Value | 4.361 |
| Price to Free Cash Flow | 16.00 |
| Earnings Yield | 9.31% |
| Market Cap | 233.08M |
| Operating PE Ratio | 6.911 |
| Normalized PE Ratio | 10.45 |